MSN 629 Ryan Turner
1. Pharmacological Plan: most appropriate pharmacological treatment. Consider
patient’s age, severity of symptoms, previous treatments, must include rationale,
patient specific dosing, duration of treatment, medication concentration, recommended
dose.
Medication and Recommended Dose Concentration (if Route/Frequency
Rationale mg/kg/day pertinent)
1.montelukast: 5mg Chew one 5mg
since the drug tablet by mouth
class is a every night at
leukotriene bedtime.
receptor agonist,
which has a direct
impact on the
inflammatory cell
responses, it
should be added to
the existing
medication
regimen (Hartert
& Bacharier,
2024).
2. budesonide for Max dose is 180 mcg Inhale 180mcg
inflammation 360 mcg/day by mouth twice
control of the a day.
bronchioles for
maintenance
therapy (Hartert &
Bacharier, 2024).
3. Ventolin HFA 90 mcg per Two puffs
(albuterol) for actuation inhaled every 4-
immediate 6 hours as
bronchodilation in needed.
the event of an
acute exacerbation
of asthma and
inability to
ventilate (Hartert
& Bacharier,
2024).
2. Comprehensive plan incorporating pharmacological and non-pharmacological
interventions to manage patient’s illness and address underlying contributing
factors.
1. Pharmacological Plan: most appropriate pharmacological treatment. Consider
patient’s age, severity of symptoms, previous treatments, must include rationale,
patient specific dosing, duration of treatment, medication concentration, recommended
dose.
Medication and Recommended Dose Concentration (if Route/Frequency
Rationale mg/kg/day pertinent)
1.montelukast: 5mg Chew one 5mg
since the drug tablet by mouth
class is a every night at
leukotriene bedtime.
receptor agonist,
which has a direct
impact on the
inflammatory cell
responses, it
should be added to
the existing
medication
regimen (Hartert
& Bacharier,
2024).
2. budesonide for Max dose is 180 mcg Inhale 180mcg
inflammation 360 mcg/day by mouth twice
control of the a day.
bronchioles for
maintenance
therapy (Hartert &
Bacharier, 2024).
3. Ventolin HFA 90 mcg per Two puffs
(albuterol) for actuation inhaled every 4-
immediate 6 hours as
bronchodilation in needed.
the event of an
acute exacerbation
of asthma and
inability to
ventilate (Hartert
& Bacharier,
2024).
2. Comprehensive plan incorporating pharmacological and non-pharmacological
interventions to manage patient’s illness and address underlying contributing
factors.
